| Availability: | |
|---|---|
INCI Name | Pentapeptide‑3, Acetyl Hexapeptide‑8, Tripeptide‑1, 1,2‑Hexanediol, Pentylene Glycol, Glycerin, Water |
Colour | Colorless to yellowish |
Appearance | Transparent solution |
Peptide Content | ≥2700 ppm |
pH | 4.0–6.0 |
Recommended Dosage | 1%–10% |
Storage | Store at room temperature (<30°C), dry, sealed, away from light. |
Scientific Mechanism & Efficacy Data
The triple‑peptide system in WKPep®SAWMPeptides 01 addresses wrinkle formation through complementary pathways. Acetyl Hexapeptide‑8 mimics the N‑terminal of SNAP‑25, competing for SNARE complex binding on the presynaptic membrane, thereby inhibiting vesicle fusion and reducing acetylcholine exocytosis. Tripeptide‑1 acts postsynaptically by blocking the nicotinic acetylcholine receptor (nmAChR), further dampening muscle contraction. Pentapeptide‑3 synergistically potentiates the effect of Acetyl Hexapeptide‑8, amplifying the overall muscle‑relaxing activity. This dual‑site inhibition ensures rapid and sustained smoothing of expression lines.
In a 15‑minute in‑vivo test involving 20 volunteers, eye masks containing WKPep®SAWMPeptides were applied; photographic analysis revealed a significant reduction in wrinkle visibility by up to 95%, demonstrating instant anti‑wrinkle efficacy. Additionally, the product has passed heavy metal and microbiological tests in compliance with the Safety and Technical Standards for Cosmetics (2015 Edition), confirming its safety for consumer use. This combination of immediate visual results, multi‑mechanism action, and stringent safety profile makes WKPep®SAWMPeptides 01 an ideal choice for formulators seeking a reliable, injectable‑free solution for dynamic wrinkle correction and facial contour lifting.